Moray Medical Revenue and Competitors

Moray Medical is working to improve the quality of life for the millions suffering with leaky heart valves. Using Moray’s proprietary microfluidic robotics, more cardiologists can safely and cost-effectively treat the large number of patients who need mitral valve clip therapies. Moray’s robotic system, with its digital user interface, enables a single hand to control the placement of a mitral clip. Powered by microfluidics, the catheter system is fast, precise, and intuitive; yet comparable in size to existing manual systems, and costs less to manufacture. By simplifying the percutaneous delivery of valve therapies, Moray Medical will enable millions of patients to benefit from this cost-effective and easy-to-learn-and-use delivery system. The structural heart market is currently one of the fastest growing medical-device fields, and that growth is accelerating with emergence of the Transcatheter Mitral Valve repair (TMVr), and more specifically the multibillion dollar Transcatheter Edge-to-Edge Repair (TEER) market. Co-founders Mark Barrish and Phillip Laby together have 50+ years of experience pioneering the core technologies and intellectual property that are now commonplace in today's surgical robotics.